Mersana Therapeutics Inc (MRSN)
2.565
-0.04
(-1.72%)
USD |
NASDAQ |
May 15, 16:00
2.565
0.00 (0.00%)
After-Hours: 20:00
Mersana Therapeutics Profit Margin (Quarterly): -208.8% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -208.8% |
| December 31, 2023 | -182.6% |
| September 30, 2023 | -541.1% |
| June 30, 2023 | -509.7% |
| March 31, 2023 | -719.9% |
| December 31, 2022 | -305.9% |
| September 30, 2022 | -1.07K% |
| June 30, 2022 | -1.22K% |
| March 31, 2022 | -2.32K% |
| December 31, 2021 | -445.3K% |
| September 30, 2021 | -413.4K% |
| June 30, 2021 | -371.9K% |
| March 31, 2021 | -315.4K% |
| December 31, 2020 | -262.2K% |
| September 30, 2020 | -204.4K% |
| June 30, 2020 | -2.49K% |
| March 31, 2020 | -153.9K% |
| Date | Value |
|---|---|
| December 31, 2019 | -38.68K% |
| September 30, 2019 | -1.99K% |
| June 30, 2019 | -8.45K% |
| March 31, 2019 | 53.37% |
| December 31, 2018 | -1.89K% |
| September 30, 2018 | -793.5% |
| June 30, 2018 | -294.8% |
| March 31, 2018 | -404.8% |
| December 31, 2017 | -428.3% |
| September 30, 2017 | -123.4% |
| June 30, 2017 | -240.0% |
| March 31, 2017 | -187.9% |
| December 31, 2016 | 10.50% |
| September 30, 2016 | -178.9% |
| June 30, 2016 | -60.60% |
| March 31, 2016 | -144.9% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-445.3K%
Minimum
Dec 2021
-182.6%
Maximum
Dec 2023
-111.3K%
Average
-2.40K%
Median
Profit Margin (Quarterly) Benchmarks
| Amicus Therapeutics Inc | -43.86% |
| Geron Corp | -18.22K% |
| Insmed Inc | -208.1% |
| Altimmune Inc | -85.52K% |
| InfuSystems Holdings Inc | -3.48% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -248.6% |
| Return on Assets | -52.07% |
| Return on Invested Capital | -169.8% |
| Operating Margin (Quarterly) | -227.2% |
| Return on Net Operating Assets | -1.09K% |